Articles by Tim Burroughs
STIC-backed Korean game publisher files for US IPO
DoubleDown Interactive, a STIC Investments-backed Korean online game publisher best known for its flagship casino offering, has filed to list in the US.
Deal focus: IMM overcomes distancing disruption
Health and safety was a priority when IMM Private Equity negotiated a $413 million carve-out of Korea Kolmar Holdings' drug outsourcing business against the backdrop of COVID-19
Ardian raises $19b for global secondaries fund
Ardian has closed its eighth global secondaries fund with $19 billion in commitments, representing the largest-ever vehicle raised for the strategy. The total includes $5 billion for co-investment.
OPTrust joins consortium bidding for Australia's Zenith Energy
Canadian pension fund OPTrust has joined Pacific Equity Partners in the consortium looking to buy Australia-listed off-grid power provider Zenith Energy for an enterprise valuation of A$250 million ($163 million).
Manulife promotes Asia private equity head
Liam Coppinger, who leads private equity investment activity in Asia Pacific for Manulife Investment Management, has been promoted to senior managing director.
Carlyle adds managing director in Japan
Reiji Terasaka has rejoined The Carlyle Group as a managing director with the Japan team after a seven-year stint in various corporate roles in Japan and the US.
China's Didi raises $500m for autonomous driving unit
SoftBank Corporation’s second Vision Fund – which currently comprises balance sheet capital from its parent – has led a $500 million funding round for the autonomous driving technology business of Chinese ride-hailing giant Didi Chuxing.
Lakeshore seeks $125m for second Thailand fund
Lakeshore Capital Asia is looking to raise $125 million for its second Thailand-focused fund and has won backing from the International Finance Corporation (IFC).
Shiyu leads $276m round for China's Mabwell Biotech
Mabwell Biotech, a Chinese drug developer with one treatment cleared for production, has raised RMB1.97 billion ($276 million) in Series A funding across two tranches led by specialist healthcare investor Shiyu Capital.
China digital enterprise services provider raises $50m
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.
KKR recruits fundraiser for Australia, New Zealand
KKR has hired Nicholas Hyde from IFM Investors as a managing director in its client partner group, with responsibility for fundraising and client relationships in Australia and New Zealand.
IMM agrees $413m Korea pharma acquisition
IMM Private Equity has agreed to acquire Korea Kolmar Holdings’ pharmaceutical contract development and manufacturing organization (CDMO) for KRW512.5 billion ($413 million).
KKR, Japanese banks pump $1.2b into Marelli
Marelli, a leading global automotive components supplier formed when KKR combined Japan’s Calsonic Kansei Corporation with Europe-based Magneti Marelli, has secured JPY130 billion ($1.2 billion) in additional funding to ride out a market downturn.
China’s Burning Rock Biotech files for US IPO
Burning Rock Biotech, a venture capital-backed, China-based provider of genetic testing services used in cancer diagnosis, has filed for an IPO in the US.
Japan carve-outs: Profit from the core
Private equity firms hoping for a coronavirus-driven uptick on Japanese corporate carve-outs must be patient – and come armed with considered value creation plans when the time arrives
Warburg Pincus raises stake in Asia real assets fund manager
Warburg Pincus has agreed to increase its ownership of ARA Asset Management – an Asia Pacific real assets fund manager that was privatized in 2016 – as China’s AVIC Trust exited the business.
Advantage completes exit from Japan's FMI
Advantage Partners has completed its exit from Japanese kitchenware products manufacturer FMI Corporation to Toho Group, a Tokyo-listed food wholesaler that bought a majority stake in the business two years ago.
PE-backed Kintor Pharma raises $240m in Hong Kong IPO
Kintor Pharmaceutical, a Chinese drug developer backed by the likes of HighLight Capital and Shenzhen Green Pine Capital Partners, posted a 7% gain on debut following a HK$1.86 billion ($240 million) Hong Kong IPO.
Bain confirms pursuit of Virgin Australia
Bain Capital is in the second round of bidding for Virgin Australia Holdings (VAH) and has pledged to give the beleaguered airline “a sustainable, long-term future.”
Unigestion loses Asia Pacific private equity head
Eric Marchand, who leads Asia Pacific private equity activity at Europe-headquartered asset manager Unigestion, will be leaving the firm in July after approximately eight years of service.
Convergence co-founder joins MDI Ventures as CEO
Donald Wihardja, co-founder of Indonesia-focused Convergence Ventures, has become CEO of MDI Ventures, the corporate VC arm of state-controlled telecommunications giant Telkom Indonesia.
B Capital forms partnership with Singapore incubator Antler
B Capital Group, a global growth-stage investor active in Southeast Asia, has formed a partnership with Singapore-based start-up incubator Antler.
Profile: Qiming Venture Partners' Duane Kuang
Having spent years as an IT advocate in a world obsessed with consumer internet start-ups, Duane Kuang of China-focused Qiming Venture Partners is seeing the tables gradually turn
Zentalis raises $20m for China drug development venture
Zentalis Pharmaceuticals, a US cancer treatment specialist that raised $165 million in an IPO last month, has secured $20 million in funding to establish a China-based joint venture.